𝔖 Bobbio Scriptorium

✦ LIBER ✦

OGX 011 produces encouraging results in NSCLC

Book ID: 120850823
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2006
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200615370-00017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

7004 Final results of a randomized phase

7004 Final results of a randomized phase II study of OGX-011 (OGX) in combination with docetaxel (DOC)/prednisone versus docetaxel/prednisone in patients with metastatic castration resistant prostate cancer (CRPC)

✍ Chi, K.N.; Hotte, S.J.; Yu, E.; Tu, D.; Eigl, B.; Tannock, I.; Saad, F.; North, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB

PD-147 A phase I study of a second gener

PD-147 A phase I study of a second generation antisenseoligonucleotide to clusterin (OGX-011) in combination with gemcitabine and cisplatin as first-line treatment for patients with advanced non-small cell lung cancer (NSCLC): Preliminary results

✍ Laskin, J.; Chi, K.; Melosky, B.; Sill, K.; Hao, D.; Canil, C.; Gleave, M.; Murr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB